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A B S T R A C T
Objective: To evaluate the economic burden of tuberculosis (TB) in Denmark,
Methods: 8,433 Danish TB-patients (1998-2010) were matched with 33,707 controls by age, gender, civil
status and geography. Health-related costs (health system contacts and –procedures, medications) and
socio-economic parameters (foregone earnings and social transfer expenses) were calculated on data
from national databases. The same information was obtained for 3,485 spouses of TB-patients, and
17,403 controls.
Results: Health-related costs were higher for cases throughout the period. Before diagnosis, cases posed s
1,180 more health costs per year than controls. Excess health costs in the 2 years around diagnosing and
treating TB were s 10,509. Cases received an average excess public transfer income of s 3,345 before vs. s
3,121 after diagnosis. Average employment income deﬁciency was s 11,635 before vs. s 13,885 after
diagnosis, but the increasing difference showed a linear shape throughout the period. Spouses also had
lower income, more social transfer, and posed higher health-related costs than matched controls.
Conclusion: We estimate the direct costs per TB patient to be s10,509. TB patients and their households
are characterized by increasingly lower employment income, lower employment rate, and higher
dependency on public transfer, but the socio/economic deterioration is rather a risk factor for TB than a
direct consequence of the disease.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Worldwide, tuberculosis (TB) remains the deadliest of conta-
gious diseases with almost 9 million new cases and 1.3 million
deaths in 2012.1 Previous studies of the economic burden of TB
have mainly focused on direct costs related to hospitalisation and
treatment of TB,2–4 though Miller et al.,5 found that direct
treatment-related expenses accounted for only a minor part of
the $ 376,255 total costs for society per TB case. In a European
context, Diel et al.,6 calculated the direct costs of diagnosing and
treating a case of pulmonary TB to be s 16,389, and indirect costs* Corresponding author. Præstehaven 69, 8210 Aarhus V, Denmark.
Tel.: +45 26360885
E-mail address: andrniel@rm.dk (A. Fløe).
http://dx.doi.org/10.1016/j.ijid.2014.12.021
1201-9712/ 2015 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).to be s 2,461, in 2004. In 2009, the sum of direct and indirect costs
had decreased to s 11,239 per adult case (excluding MDR-TB)7;
close to the s10,282 average in Western Europe according to a
2013 review.8 The decrease in costs reﬂects increasing out-patient
treatment of TB. Incorporating indirect costs of TB has previously
been based on estimated loss in productivity as factual data have
generally not been available.
Denmark has a low TB incidence (2012: 6.5 per 100.000 per
year).9 About 66% of TB cases are found among immigrants. The
responsibility for treatment and follow-up of TB patients is shared
among centralized departments of pulmonary and infectious
diseases, while contact investigation procedures are performed at
a handful of public departments of respiratory diseases. Guidelines
for TB treatment and contact investigations are deﬁned in the
national Danish TB-program.10 In contrast to comparable countries,ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Table 1
Distribution of age, gender and educational level among cases and controls
Case Control
Age N %-Share N %-Share
<20 1,140 13.5 4,559 13.5
20-29 1,136 13.5 4,542 13.5
30-39 1,492 17.7 5,964 17.7
40-49 1,359 16.1 5,432 16.1
50-59 1,104 13.1 4,406 13.1
60-69 874 10.4 3,495 10.4
70-79 847 10 3,387 10
>=80 481 5.7 1,922 5.7
All 8,433 100 33,707 100
Gender N %-Share N %-Share
Male 4,668 55.4 18,655 55.3
Female 3,765 44.6 15,052 44.7
All 8,433 100 33,707 100
Education N %-Share N %-Share
Primary 3,197 37.9 10,438 31.0
Secondary 508 6.0 2,219 6.6
Vocational 1,598 18.9 9,253 27.5
Short college 235 2.8 1,280 3.8
Medium college 450 5.3 3,221 9.6
Master/phd 211 2.5 1,791 5.3
Unknown 2,234 26.5 5,505 16.3
All 8,433 100.0 33,707 100
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primarily due to active disease transmission in high risk sub-
populations.11 In Denmark, data on healthcare contacts, medication
use, employment information, and social determinants at the person
level are linked by the unique civil registration number. This allows
reliable calculation of direct and indirect costs of a given disease, and
has previously contributed important knowledge of the ﬁnancial
burden of a number of chronic diseases.12–14
To our knowledge, no previous studies have evaluated the
impact of diagnosing and treating TB on social and economic
parameters over time, nor have they addressed the socioeconomic
status of spouses of TB patients. The aim of this study was to evaluate
health-related costs and socio-economic parameters of patients
with active TB and their spouses both before and after diagnosis and
treatment in a national, retrospective case-control study.
2. Methods
In Denmark, all hospital contacts are registered in the National
Patient Registry (NPR).15 The NPR includes administrative infor-
mation, primary and secondary diagnoses and information on
diagnostic and treatment procedures using the International
Statistical Classiﬁcation of Diseases and Related Health Problems
10th Revision (ICD-10). Primary sector contacts (general practice
and specialist care) and the use of medications are recorded in the
databases of the National Health Security and the Danish Health
and Medicines Agency, respectively.
We extracted data on all patients with a primary or secondary
ICD-10 diagnosis of A15 through A19 in the period 1998-2010
(12 years). This includes pulmonary and extra pulmonary TB, but
not latent TB (LTBI). We did not control for MDR-TB status, as the
incidence in Denmark is very low (2011: 0.48% of TB cases9). Data
were available for the entire observation period, allowing us to
trace patients both retrospectively and prospectively relative to
the time of diagnosis.
The Danish Civil Registration System contains information
about cohabitation status, marital status, social factors, employ-
ment, education, income, pensions etc.16. We randomly selected
controls matched by age, gender, geographical area and marital
status. Patient-to-control ratio was 1:4.
Data from patients and matched controls that could not be
identiﬁed in the Income Statistics database were excluded, but
more than 99% of the observations were successfully matched. If a
patient or control was not present in the registry on 1 January in a
given year because of death, imprisonment or emigration, the
corresponding control or case was excluded.
Spouses were identiﬁed by having the same address as a case or
by marital status. The random control group for spouses was
generated similarly to the control group for TB patients.
Patients, spouses and matched controls were followed through
the study period from 1998 to 2010 (or until death). If diagnosis of
TB was made in 1998, we were able to follow that individual
11 years forward in time. If the diagnosis was established in 2010,
we were able to trace that individual 11 years backwards in time. If
the diagnosis was made in 2006, we could trace eight years
backwards and four years forward etc. This allowed us to study
changes in health costs and socio-economic parameters relative to
the TB diagnosis reﬂecting the impact of TB on these parameters,
while baseline differences between cases and controls allowed us
to study fundamental socio-economic differences between cases
and controls (risk factors for TB).
Health-related costs covered in- and out-patient treatment and
medicine expenditures. Average national costs of hospitalisation
and outpatient treatment for speciﬁc diagnosis-related groups
(DRG) were calculated. These data were obtained from Danish
Ministry of Health by DRG. It is average case-mix of in- and out-patient costs, updated for every year. Speciﬁc patient-related out-
patient costs were added. Medicine expenditures were obtained
from the Danish Health and Medicines Agency as the retail price of
each drug (including dispensing costs) multiplied by the number of
transactions. The frequencies and costs of consultations with
general practitioners and other specialists were based on National
Health Security data.
Socio-economic parameters included costs for society and
patients, such as reduced employment beneﬁts and social transfer
payments. In Denmark, social transfer payments comprise
subsistence allowances, pensions, social security, social assistance,
publicly funded education support, and others. Indirect costs were
based on income ﬁgures from Income Statistics. Costs were
measured on an annual basis and adjusted to 2010 prices using
Statistics Denmark’s general price index. All costs were calculated
in DKK and converted to Euros (s1: DKK 7.45).
2.1. Statistical analysis and ethical considerations
The study was approved by the Danish Data Protection Agency.
Data handling did not involve revealing the identity of any patients
or control subjects, so ethical approval was not required. Some
patients had extremely high resource consumption, leading to a
skewed distribution. From a societal perspective, this should be
reﬂected in the results, and therefore, data were presented as
means rather than as medians. Statistical analysis was performed
using SAS 9.1.3 (SAS, Inc., Cary, NC, USA). Statistical signiﬁcance of
the cost estimates was established from two-sided t-tests based on
bootstrap analysis.17,18 A signiﬁcance level of 0.05 was assumed for
all tests.
3. Results
3.1. Demography
We identiﬁed and extracted 8,433 patients from the NPR, and
33,707 matched controls. Age, gender and educational level of the
study population are shown in Table 1. We found more male
(55.4%) than female (44.6%) patients, consistent with recent
A. Fløe et al. / International Journal of Infectious Diseases 32 (2015) 183–190 185Danish data.19 An incidence peak was seen in the age group of 30-
39 years. Generally, fewer cases had a college or university degree.
The education levels were more often unknown for cases than for
controls.
3.2. Health-related costs: Outpatient clinic, hospital, primary care and
drugs
The health-related costs were signiﬁcantly higher for cases than
for controls in the entire study period (Figure 1 A), but as expected,
the total health costs for cases showed a peak around the time of0
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Figure 1. Total health expenses, cases and contdiagnosis. The mean case-to-control difference prior to diagnosis
was s 1,180. Excess health-related costs in years 0-1 was s 10,509.
The case-to-control difference levelled off from the second year
after diagnosis, and mean case-to-control difference after the
second year constituted s 1,322 per year. The largest health-
related costs covered inpatient treatment; this was evident
throughout the study period before as well as after diagnosis. In
year 0-1, inpatient treatment constituted 76.6% of all health costs
(81.3% in year 0 and 65.2% in year 1) (Figure 2). Health-related
costs for both genders were higher for cases than controls in all age
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Figure 2. The contribution of different cost categories (inpatient treatment, outpatient treatment, public health insurance expenses and expenses to medication) to the total
health costs for cases, relative to the year of TB diagnosis.
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income, public pensions and sickness beneﬁt
Throughout the study period, average employment income
was lower for cases than controls; the opposite was true for social
transfer income. (Figure 1 B-C) All differences between the groups
regarding employment and social transfer income were statisti-
cally signiﬁcant (p<0.05, data not shown). Average difference in
employment income was s 11,635 in years prior to diagnosis,
and s 13,885 after diagnosis. Average difference in total public
transfer income was s 3,345 before diagnosis, and s 3,121
after diagnosis. However, changes in case-to-control difference
regarding both employment income and public transfer income
over time showed an approximately linear conformation (data not
shown), and no major change in the trend was seen at the time of
diagnosis.
Looking at employment and social transfer income distributed
in age and gender groups (Figure 3), we found that income from
employment was higher among controls in all age groups. For
controls, social transfer income showed an increase at retirement
age (a public pension is paid to all Danish citizens above 65 years
when retiring). For cases, public transfer income was higher prior
to retirement age, and increasing with age. The share of cases and
controls receiving employment income and public transfer income
is shown in Table 2.3.4. Spouses of TB patients
3,485 spouses were included and matched to 17,403 controls.
Being a spouse of a TB-patient was associated with increased social
transfer income and lower employment income compared with
controls (Figure 4 B-C). The difference was signiﬁcant except in
year 11, where few individuals contributed data (data not shown).
The annual total health-related costs of spouses were higher than
of controls (Figure 4 A), but only signiﬁcantly in a period from four
years before diagnosis to three years after diagnosis. The number of
spouses and controls receiving employment income and public
transfer income is shown in Table 2.
4. Discussion
Overall, we found that TB patients had higher health-related
costs than matched controls long before the diagnosis of TB, and
peaking at the time of diagnosing and treating the disease. Indirect
costs for society as well as for the patients were higher for cases
than for controls, up to 11 years prior to diagnosis. Of greatest
importance was inferior employment income, which represents
lost productivity for society as well as inferior income at individual
level.
The education level data for cases and controls are generally
robust for persons aged 14-80 years. For those above 80 years,
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Figure 3. Expenses distributed for age and gender. Total health expenses for cases (3A) and controls (3B), employment income for cases (3C) and controls (3D) and public
transfer income for cases (3E) and controls (3F).
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Table 2
Share or cases and controls, and spouses and controls, receiving public transfer income. Person years after diagnosis of TB only. Some persons received more than one category
of public transfer income in the included years.
Cases Spouses
Case Control P-value Spouse Control P-value
Income from employment % 31.3 58.5 <0.001 43.8 69.6 <0.001
Public transfer income total % 68.3 47.3 <0.001 66.7 48.6 <0.001
Pension % 15.7 18.7 <0.001 15.7 14.9 0.193
Other public transfers % 47.5 20.6 <0.001 44.3 21.9 <0.001
Sickpay (public funded) % 9.8 12.0 <0.001 11.9 16.8 <0.001
A. Fløe et al. / International Journal of Infectious Diseases 32 (2015) 183–190188information is scarce, as registration from the different teaching
institutions to the Danish Civil Registration System did not begin
until 1970. This explains most of the controls with unknown
education level, while unknown status was more common among
cases. The majority of these probably had no education, many
being immigrants from low-income countries, representing an
important risk group for TB, not necessarily comparable to the
controls with unknown status. In order to investigate the impact of0
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Figure 4. Spouses of TB-patients. Total health expenses for spouses and controls (4A), 
spouses and controls (4C), relative to the year of diagnosis of the TB-case.educational level as a marker of socio-economic standing, we
computed a general linear model (GLM), controlling for educa-
tional level including unknown status, to eliminate the effect of
educational level. The signiﬁcance level in case-to-control
differences regarding health costs, income and social transfer
did not change, except for health costs towards spouses in years 8,
9 and 10 after diagnosis, when few spouses and controls
contributed data. The GLM illustrates that case-to-control0 1 2 3 4 5 6 7 8 9 10 11
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but it was not feasible for further analysis, as this would force us to
exclude all cases and controls with unknown status, representing a
clinically very important group of TB patients.
The total costs of diagnosing and treating a person with TB was
approximately s 10,500, based on the excess costs in year 0 and 1,
as we assume that these were attributable to TB. Standard TB
treatment takes 6-9 months, though some cases require longer
treatment. All economic data were registered per calendar year,
whereby a large share of the expenses was denoted in year
1. Furthermore, the shape of the direct health-cost curve (Figure 1)
supports that the excess health-related costs were concentrated in
these two years. Spouses also posed higher health-related costs
than matched controls, peaking around time of diagnosis, probably
reﬂecting contact investigation, treatment for LTBI etc. Generally,
around 30% of close contacts have LTBI,20 often requiring
investigation for active TB and treatment of LTBI.
A recent review estimated the direct costs per TB patient in
Western Europe to be s 7,848 per drug-susceptible case,8 which is
close to the costs in Germany of s7,931 according to Diel et al.,7 in
2009. These estimates were calculated on basis of number of
hospital days, medicine expenditures, and outpatient costs speciﬁc
for TB. The higher amount in our study may be explained by
including total health costs, possibly including diseases leading to
a risk of TB (e.g. COPD,21 end-stage kidney disease,22 diabetes
mellitus23,), but also the costs of secondary effects of TB and
treatment such as difﬁcult management of diabetes, deterioration
in COPD, clinical depression treated in either primary or secondary
sector etc . Average per-day costs of inpatient treatment have been
estimated to be higher in Denmark compared with most other
Western European countries.24 Our data did not include costs
related to contact investigation procedures; as such costs are not
linked to the index TB patient but to the exposed contacts
investigated. A prospective collection of data on contact investi-
gation procedures would improve our knowledge of the economic
aspects of this matter, and would need to take into account the
estimated number of TB cases avoided and the reduced costs from
TB cases identiﬁed at an earlier disease stage.
We found that persons developing TB as well as their spouses
had lower employment income and higher dependency on public
transfer income than matched controls. This was seen throughout
the study period and also 11 years prior to diagnosis. Inferior
employment income was the main contributor to these ‘‘indirect
costs’’. They showed a linear shape over the years investigated,
suggesting that the increasing income difference is a characteristic
of the population group at risk of acquiring TB, rather than a direct
consequence of TB disease. At the time of TB diagnosis, only 22.6%
of TB cases vs. 54.5% of controls were gainfully employed. Taking
these numbers into account, it is not surprising that the changes in
income difference due to TB disease and treatment are small –
simply because the majority of cases were unemployed already at
the time of diagnosis. With regard to public transfer income, no
major change was seen either before or after diagnosis or at the
time of diagnosis for TB cases and their spouses. Therefore, the
higher average public transfer income is also a characteristic of the
population at risk of TB, rather than a consequence of TB disease.
In similar studies, indirect costs have been calculated from
average sick leave. In comparison, we did not ﬁnd a signiﬁcant
increase in case-to-control difference in income around the time of
TB disease – probably because few TB patients were employed. In
our point of view, the socio-economic deroute that constitutes a
major risk factor for TB is of much greater societal importance, also
economically speaking, than absence from work in the beginning
of TB treatment. Diagnosing and treating TB requires close contact
with healthcare professionals during several months. If this
opportunity could be used to take precautions to prevent furtherdeterioration, it would yield a potential for signiﬁcant economic
beneﬁt for society as well as for patients.
The diagnosis and treatment of TB lead to major costs for
society. The main part of health-related costs results from
in-hospital treatment. Patients should only be admitted to hospital
if they are severely ill, or if there is reason to believe that the
patient cannot manage treatment in an out-patient setting. A
strengthening of the out-patient management of patients, for
example including TB consultations at home, in homeless shelters
etc. could potentially reduce expensive in-patient treatments.
However, earlier diagnosis of TB is probably the most effective way
to reduce the need for hospitalisation of TB-patients, as well as to
reduce overall costs due to complications and co-morbidities. TB is
concentrated in certain high-risk communities in Denmark,11 and
screening for TB in these communities may be more cost-effective
than contact investigation procedures.
There are some limitations to this study: Our ﬁndings depend
on TB being diagnosed and reported correctly by clinicians. A
previous study evaluated the NPR diagnoses of TB, and found a
good positive predictive value (PPV).25 The number of TB cases
reported to the National TB Register (Statens Serum Insitut,
Copenhagen) in the years investigated was 5,594,26 and thus, the
number of cases in this study was 33% higher. This may be due to
underreporting of TB, to false-positive TB diagnoses or a
combination. Previous studies in comparable countries have
estimated underreporting of TB to be 7-27%,27,28 while a study
in Greece estimated an 80% underreporting.29 Also, including
spouses of TB patients implies certain concerns. Potentially,
spouses of TB patients having active TB (being either infected by
or being the source of infection of the case) could confound our
ﬁndings. Yet, the risk of active TB in household contacts is around
1.4% in high-income countries,20 and therefore, we assume that the
effect of spouses having active TB would be minor. Finally, we did
not provide background ethnicity data of either the study
populations or the control groups, as we were not able to extract
reliable ethnicity data from the registers used.
In conclusion, TB cases in Denmark are characterised by higher
health-related costs than matched controls, also many years prior
to TB diagnosis. The direct health-related costs peaked two years
around diagnosis. Health-related costs per TB case were estimated
to constitute approximately s 10,500. TB patients and their
spouses are characterised by inferior employment and income, and
higher dependency on social transfer income, compared with
matched controls. These unfortunate socio-economic character-
istics seemed to deteriorate over time and did not change
signiﬁcantly at the time of acquiring TB. TB in Denmark is
connected to a pattern of socio/economic deroute, which in itself is
much more dramatic than the indirect consequences of TB.
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